Cytokinetics Inc. buy Barclays PLC
Start price
06.04.26
/
50%
€55.52
Target price
06.04.27
€82.47
Performance (%)
-9.91%
Price
29.04.26
€51.04
Summary
This prediction is currently active. With a performance of -9.91%, the BUY prediction for Cytokinetics Inc. by Barclays_PLC is down slightly. This prediction currently runs until 06.04.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Cytokinetics Inc. | -9.887% |
| iShares Core DAX® | -1,50 % |
| iShares Nasdaq 100 | 1,38 % |
| iShares Nikkei 225® | -1,99 % |
| iShares S&P 500 | 0,35 % |
Comments by Barclays_PLC for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (CYTK) had its price target raised by Barclays PLC from $87.00 to $95.00. They now have an "overweight" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Barclays_PLC for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€53.50
28.01.26
28.01.26
€72.55
28.01.27
28.01.27
-4.60%
29.04.26
29.04.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€41.60
03.09.25
03.09.25
€61.04
03.09.26
03.09.26
22.69%
29.04.26
29.04.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€29.00
08.05.25
08.05.25
€46.79
08.05.26
08.05.26
76.00%
29.04.26
29.04.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€33.60
24.04.25
24.04.25
€48.44
24.04.26
24.04.26
63.39%
25.04.26
25.04.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€46.40
23.05.24
23.05.24
€87.72
23.05.25
23.05.25
-42.24%
24.05.25
24.05.25